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This issue of Clinical Trials contains the proceedings of the fifth in a series of symposia held at the University of Pennsylvania on current statistical issues in clinical trials. This symposium, held in spring 2012, focused on emerging statistical issues in biomarker validation for clinical trials, a topic highly relevant to the ever-increasing concerns about clinical trial efficiency While the titles of the papers in Table 1 biomarker validation and the approach to assessing clinical utility along with statistical validation. Expert panels provided thoughtful commentary on the presentations, and there were provocative and insightful questions and comments from the floor; these discussions are included along with the articles. The Penn conference series is aimed at facilitating advances in approaches to the statistical design, implementation and analysis of clinical trials. Earlier conferences in this series focused on proof-ofconcept studies and 'go-no go' decision-making [1] , development of targeted therapies [2] , comparative effectiveness studies [3] , and emerging statistical issues in the conduct and monitoring of clinical trials [4] .
